Conformationally Restricted Grp94-Selective Inhibitors
Saved in:
Main Authors: | Hao Xu, Kyler Pugh, Brian S. J. Blagg |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2025-01-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.4c06661 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The clinical and prognostic evaluation of GRP94 immunoexpression in Caucasian patients with colorectal adenocarcinoma
by: Marlena Brzozowa-Zasada, et al.
Published: (2019-07-01) -
Hepatic Overexpression of GRP94 in a Rabbit Model of Parenteral Nutrition-Associated Liver Disease
by: Xueping Zhu, et al.
Published: (2015-01-01) -
Assessment of Hsp90β-selective inhibitor safety and on-target effects
by: Tyelor S. Reynolds, et al.
Published: (2025-01-01) -
Two-component system GrpP/GrpQ promotes pathogenicity of uropathogenic Escherichia coli CFT073 by upregulating type 1 fimbria
by: Xueping Li, et al.
Published: (2025-01-01) -
Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis
by: Xiaofan Sun, et al.
Published: (2025-02-01)